Total Payments
$25,501
2024 Payments
$1,119
Companies
3
Transactions
40
Medicare Patients
2,662
Medicare Billing
$322,374
Payment Breakdown by Category
Research$13,750 (53.9%)
Consulting$7,875 (30.9%)
Travel$2,005 (7.9%)
Food & Beverage$1,170 (4.6%)
Other$700.00 (2.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $13,750 | 6 | 53.9% |
| Consulting Fee | $7,875 | 10 | 30.9% |
| Travel and Lodging | $2,005 | 7 | 7.9% |
| Food and Beverage | $1,170 | 16 | 4.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $700.00 | 1 | 2.7% |
Payments by Type
Research
$13,750
6 transactions
General
$11,751
34 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Edwards Lifesciences Corporation | $17,561 | 19 | $0 (2021) |
| Abbott Laboratories | $7,820 | 20 | $0 (2024) |
| Medtronic, Inc. | $119.00 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,119 | 2 | Abbott Laboratories ($1,000) |
| 2022 | $1,000 | 1 | Abbott Laboratories ($1,000) |
| 2021 | $5,000 | 1 | Edwards Lifesciences Corporation ($5,000) |
| 2020 | $2,000 | 2 | Abbott Laboratories ($2,000) |
| 2019 | $5,825 | 4 | Edwards Lifesciences Corporation ($3,825) |
| 2018 | $4,633 | 16 | Edwards Lifesciences Corporation ($2,813) |
| 2017 | $5,924 | 14 | Edwards Lifesciences Corporation ($5,924) |
All Payment Transactions
40 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Abbott Laboratories | XIENCE V (Device) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Vascular | ||||||
| 02/05/2024 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $119.00 | General |
| Category: Transcatheter Valve Systems | ||||||
| 05/11/2022 | Abbott Laboratories | PORTICO (Device) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Structural Heart | ||||||
| 02/04/2021 | Edwards Lifesciences Corporation | — | — | Cash or cash equivalent | $5,000.00 | Research |
| Study: Edwards EVOQUE Eos MISCEND Study 2013-05C | ||||||
| 11/04/2020 | Abbott Laboratories | Xience V coronary stent system (Device) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Vascular | ||||||
| 02/26/2020 | Abbott Laboratories | Tricuspid Valve Repair System (Device) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Vascular | ||||||
| 11/08/2019 | Edwards Lifesciences Corporation | EDWARDS INTUITY Elite valve system (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: Pericardial Heart Valves | ||||||
| 08/28/2019 | Abbott Laboratories | Tricuspid Valve Repair System (Device) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Vascular | ||||||
| 05/29/2019 | Abbott Laboratories | Tricuspid Valve Repair System (Device) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Vascular | ||||||
| 05/15/2019 | Edwards Lifesciences Corporation | — | — | Cash or cash equivalent | $3,125.00 | Research |
| Study: Early Feasibility Study of the CardiAQ Transcatheter Mitral Valve Implantation TMVI System 2013-05C | ||||||
| 12/14/2018 | Abbott Laboratories | Mitra Clip system (Device) | Travel and Lodging | Cash or cash equivalent | $216.56 | General |
| Category: Vascular | ||||||
| 12/14/2018 | Abbott Laboratories | Mitra Clip system (Device) | Food and Beverage | In-kind items and services | $113.83 | General |
| Category: Vascular | ||||||
| 12/14/2018 | Abbott Laboratories | Mitra Clip system (Device) | Food and Beverage | In-kind items and services | $97.76 | General |
| Category: Vascular | ||||||
| 12/14/2018 | Abbott Laboratories | Mitra Clip system (Device) | Food and Beverage | In-kind items and services | $40.17 | General |
| Category: Vascular | ||||||
| 12/14/2018 | Abbott Laboratories | Mitra Clip system (Device) | Travel and Lodging | Cash or cash equivalent | $21.32 | General |
| Category: Vascular | ||||||
| 12/14/2018 | Abbott Laboratories | Mitra Clip system (Device) | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: Vascular | ||||||
| 12/13/2018 | Abbott Laboratories | Mitra Clip system (Device) | Travel and Lodging | Cash or cash equivalent | $403.97 | General |
| Category: Vascular | ||||||
| 12/13/2018 | Abbott Laboratories | Mitra Clip system (Device) | Food and Beverage | In-kind items and services | $169.93 | General |
| Category: Vascular | ||||||
| 12/13/2018 | Abbott Laboratories | Mitra Clip system (Device) | Food and Beverage | In-kind items and services | $147.31 | General |
| Category: Vascular | ||||||
| 12/13/2018 | Abbott Laboratories | Mitra Clip system (Device) | Food and Beverage | In-kind items and services | $91.06 | General |
| Category: Vascular | ||||||
| 12/13/2018 | Abbott Laboratories | Mitra Clip system (Device) | Food and Beverage | In-kind items and services | $42.51 | General |
| Category: Vascular | ||||||
| 12/13/2018 | Abbott Laboratories | Mitra Clip system (Device) | Food and Beverage | In-kind items and services | $40.17 | General |
| Category: Vascular | ||||||
| 12/13/2018 | Abbott Laboratories | Mitra Clip system (Device) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Vascular | ||||||
| 12/12/2018 | Abbott Laboratories | Mitra Clip system (Device) | Travel and Lodging | Cash or cash equivalent | $403.97 | General |
| Category: Vascular | ||||||
| 06/29/2018 | Edwards Lifesciences Corporation | — | — | Cash or cash equivalent | $1,875.00 | Research |
| Study: Early Feasibility Study of the CardiAQ Transcatheter Mitral Valve Implantation TMVI System 2013-05C | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Early Feasibility Study of the CardiAQ Transcatheter Mitral Valve Implantation TMVI System 2013-05C | Edwards Lifesciences Corporation | $5,938 | 3 |
| Edwards EVOQUE Eos MISCEND Study 2013-05C | Edwards Lifesciences Corporation | $5,000 | 1 |
| Edwards CardiAQ EFS Study 2013-05C | Edwards Lifesciences Corporation | $2,188 | 1 |
| Active Pivotal Trial 2017-05 | Edwards Lifesciences Corporation | $625.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 684 | 902 | $322,262 | $87,498 |
| 2022 | 13 | 625 | 787 | $258,560 | $69,644 |
| 2021 | 18 | 780 | 977 | $365,330 | $99,194 |
| 2020 | 15 | 573 | 686 | $254,553 | $66,038 |
Total Patients
2,662
Total Services
3,352
Medicare Billing
$322,374
Procedure Codes
60
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 33361 | Replacement of aortic valve through the skin and femoral artery | Facility | 2023 | 38 | 38 | $57,380 | $23,293 | 40.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 135 | 179 | $59,786 | $13,420 | 22.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 53 | 133 | $42,693 | $13,400 | 31.4% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2023 | 43 | 44 | $27,104 | $7,310 | 27.0% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 14 | 15 | $26,475 | $6,825 | 25.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 17 | 31 | $26,629 | $5,547 | 20.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 34 | 34 | $20,876 | $4,993 | 23.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 29 | 34 | $15,232 | $4,044 | 26.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 26 | 26 | $16,562 | $3,989 | 24.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 160 | 229 | $6,870 | $1,509 | 22.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 16 | 17 | $3,808 | $1,139 | 29.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 17 | 17 | $3,808 | $890.61 | 23.4% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 69 | 72 | $12,960 | $728.70 | 5.6% |
| 93790 | Ambulatory blood pressure monitoring, 1 day or longer, with review, interpretation and report | Facility | 2023 | 33 | 33 | $2,079 | $411.48 | 19.8% |
| 33361 | Replacement of aortic valve through the skin and femoral artery | Facility | 2022 | 31 | 31 | $46,810 | $19,613 | 41.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 135 | 183 | $61,122 | $13,923 | 22.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 49 | 107 | $34,347 | $9,221 | 26.8% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2022 | 39 | 39 | $24,024 | $7,256 | 30.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 27 | 27 | $16,578 | $4,203 | 25.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 25 | 25 | $15,925 | $3,638 | 22.8% |
| 93456 | Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2022 | 14 | 14 | $11,046 | $3,412 | 30.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 11 | 17 | $14,603 | $3,134 | 21.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 16 | 16 | $7,168 | $1,890 | 26.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 145 | 192 | $5,760 | $1,251 | 21.7% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2022 | 83 | 83 | $14,940 | $878.09 | 5.9% |
About Dr. Joseph Carrozza, M.D
Dr. Joseph Carrozza, M.D is a Cardiovascular Disease healthcare provider based in Brighton, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1639104714.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Carrozza, M.D has received a total of $25,501 in payments from pharmaceutical and medical device companies, with $1,119 received in 2024. These payments were reported across 40 transactions from 3 companies. The most common payment nature is "" ($13,750).
As a Medicare-enrolled provider, Carrozza has provided services to 2,662 Medicare beneficiaries, totaling 3,352 services with total Medicare billing of $322,374. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Brighton, MA
- Active Since 07/11/2006
- Last Updated 03/11/2025
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1639104714
Products in Payments
- Tricuspid Valve Repair System (Device) $3,000
- Mitra Clip system (Device) $1,820
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $1,236
- PORTICO (Device) $1,000
- XIENCE V (Device) $1,000
- Xience V coronary stent system (Device) $1,000
- EDWARDS INTUITY Elite valve system (Device) $700.00
- COREVALVE EVOLUT R (Device) $119.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Brighton
Michael Orlov, M.d, M.D
Cardiovascular Disease — Payments: $49,348
Cardiovascular Disease $49,348
Mohamed Khan, Md, MD
Cardiovascular Disease — Payments: $33,657
Cardiovascular Disease $33,657
Douglas Losordo, Md, MD
Cardiovascular Disease — Payments: $17,893
Cardiovascular Disease $17,893
Dr. Ayodeji Dina, M.d, M.D
Cardiovascular Disease — Payments: $12,430
Cardiovascular Disease $12,430
Donald Rabor, Md, MD
Cardiovascular Disease — Payments: $11,153
Cardiovascular Disease $11,153
Brian Allen, M.d, M.D
Cardiovascular Disease — Payments: $9,799
Cardiovascular Disease $9,799